{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T23:11:33Z","timestamp":1788909093206,"version":"build-2803163510"},"reference-count":110,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T00:00:00Z","timestamp":1594857600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibiotics"],"abstract":"<jats:p>Antimicrobial resistance necessitates action to reduce and eliminate infectious disease, ensure animal and human health, and combat emerging diseases. Species such as Acinetobacter baumanniii, vancomycin resistant Enterococcus, methicillin resistance Staphylococcus aureus, and Pseudomonas aeruginosa, as well as other WHO priority pathogens, are becoming extremely difficult to treat. In 2017, the EU adopted the \u201cOne Health\u201d approach to combat antibiotic resistance in animal and human medicine and to prevent the transmission of zoonotic disease. As the current therapeutic agents become increasingly inadequate, there is a dire need to establish novel methods of treatment under this One Health Framework. Bacteriophages (phages), viruses infecting bacterial species, demonstrate clear antimicrobial activity against an array of resistant species, with high levels of specificity and potency. Bacteriophages play key roles in bacterial evolution and are essential components of all ecosystems, including the human microbiome. Factors such are their specificity, potency, biocompatibility, and bactericidal activity make them desirable options as therapeutics. Issues remain, however, relating to their large-scale production, formulation, stability, and bacterial resistance, limiting their implementation globally. Phages used in therapy must be virulent, purified, and well characterized before administration. Clinical studies are warranted to assess the in vivo pharmacokinetics and pharmacodynamic characteristics of phages to fully establish their therapeutic potential.<\/jats:p>","DOI":"10.3390\/antibiotics9070414","type":"journal-article","created":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T10:54:46Z","timestamp":1594896886000},"page":"414","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":70,"title":["Bacteriophages and the One Health Approach to Combat Multidrug Resistance: Is This the Way?"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1240-5315","authenticated-orcid":false,"given":"Mary","family":"Garvey","sequence":"first","affiliation":[{"name":"Department of Life Science, Sligo Institute of Technology, Sligo, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,7,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_2","unstructured":"(2020, June 10). WHO. Available online: https:\/\/www.who.int\/news-room\/detail\/29-04-2019-new-report-calls-for-urgent-action-to-avert-antimicrobial-resistance-crisis."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Dafale, N.A., Srivastava, S., and Purohit, H.J. (2020). Zoonosis: An emerging link to antibiotic resistance under \u201cOne Health approach\u201d. Indian J. Microbiol.","DOI":"10.1007\/s12088-020-00860-z"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1179\/2047773215Y.0000000030","article-title":"Antimicrobial resistance: A global multifaceted phenomenon","volume":"109","author":"Prestinaci","year":"2015","journal-title":"Pathog. Glob. Health"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1177\/2042098614554919","article-title":"Antimicrobial resistance: Risk associated with antibiotic overuse and initiatives to reduce the problem","volume":"5","author":"Llor","year":"2014","journal-title":"Ther. Adv. Drug Saf."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Qu, J., Huang, Y., and Lv, X. (2019). Crisis of antimicrobial resistance in China: Now and the future. Front. Microbiol., 10.","DOI":"10.3389\/fmicb.2019.02240"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Yousfi, H., Ranque, S., Rolain, J.M., and Bittar, F. (2019). In vitro polymyxin activity against clinical multidrug-resistant fungi. Antimicrob. Resist. Infect. Control, 8.","DOI":"10.1186\/s13756-019-0521-7"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/bjh.12896","article-title":"Current status of antifungal resistance and its impact on clinical practice","volume":"166","author":"Mellado","year":"2014","journal-title":"Br. J. Haematol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Forsberg, K., Woodworth, K., Walters, M., Berkow, E.L., Jackson, B., Chiller, T., and Vallabhaneni, S. (2018). Candida auris: The recent emergence of a multidrug-resistant fungal pathogen. Med. Mycol.","DOI":"10.1093\/mmy\/myy054"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Van de Pol, J.A.A., van Best, N., Mbakwa, C.A., Thijs, C., Savelkoul, P.H., Arts, I.C.W., and Penders, J. (2017). Gut colonization by methanogenic archaea is associated with organic dairy consumption in children. Front. Microbiol., 8.","DOI":"10.3389\/fmicb.2017.00355"},{"key":"ref_11","first-page":"26","article-title":"Antibiotic resistance: An important issue for public health safety","volume":"1","author":"Savage","year":"2017","journal-title":"Ann. Microbiol. Res."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Meade, E., Slattery, M.A., and Garvey, M. (2020). Bacteriocins, potent antimicrobial peptides and the fight against multi drug resistant species. Resistance is futile?. Antibiotics, 9.","DOI":"10.3390\/antibiotics9010032"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e25917","DOI":"10.5812\/jjm.25917","article-title":"Isolation and characterization of a Myoviridae MJ1 bacteriophage against multi-drug resistant Escherichia coli 3","volume":"8","author":"Jamal","year":"2015","journal-title":"Jundishapur J. Microbiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e130265","DOI":"10.3201\/eid1912.130265","article-title":"Toward proof of concept of a One Health approach to disease prediction and control","volume":"19","author":"Rabinowitz","year":"2013","journal-title":"Emerg. Infect. Dis."},{"key":"ref_15","first-page":"2","article-title":"A comprehensive review of current environmental pollutants of pharmaceutical, agricultural and industrial origin","volume":"10","author":"Doyle","year":"2020","journal-title":"Eur. J. Exp. Biol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.prevetmed.2013.09.010","article-title":"Transdisciplinary research for complex One Health issues: A scoping review of key concepts","volume":"112","author":"Min","year":"2013","journal-title":"Prev. Vet. Med."},{"key":"ref_17","first-page":"63","article-title":"Antibiotic resistance in bacteria-an emerging public health problem","volume":"15","author":"Komolafe","year":"2003","journal-title":"Malawi Med. J."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1080\/10408398.2015.1077192","article-title":"Antimicrobial resistance: A global emerging threat to public health systems","volume":"57","author":"Ferri","year":"2015","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/s10393-019-01415-5","article-title":"Critical importance of a One Health approach to antimicrobial resistance","volume":"16","author":"White","year":"2019","journal-title":"EcoHealth"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/PAT.0000000000000237","article-title":"Resistance mechanisms in Enterobacteriaceae","volume":"47","author":"Partridge","year":"2015","journal-title":"Pathology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.19080\/NFSIJ.2019.08.555747","article-title":"Chronic bovine mastitis: A food safety issue and public health hazard","volume":"8","author":"Garvey","year":"2019","journal-title":"Nutr. Food Sci. Int. J."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1086\/529198","article-title":"Antimicrobial resistance: Acinetobacter baumannii: Epidemiology, antimicrobial resistance, and treatment options","volume":"46","author":"Maragakis","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.1128\/AEM.00465-15","article-title":"Dynamics of Escherichia coli virulence factors in dairy herds and farm environments in a longitudinal study in the United States","volume":"81","author":"Lambertini","year":"2015","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12934-015-0241-5","article-title":"Detoxifying Escherichia coli for endotoxin-free production of recombinant proteins","volume":"14","author":"Mamat","year":"2015","journal-title":"Microb. Cell Factories"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"291","DOI":"10.4103\/0974-777X.68538","article-title":"Multidrug resistant Acinetobacter","volume":"2","author":"Manchanda","year":"2010","journal-title":"J. Glob. Infect. Dis."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Bhagirath, A.Y., Li, Y., Somayajula, D., Dadashi, M., Badr, S., and Duan, K. (2016). Cystic fibrosis lung environment and Pseudomonas aeruginosa infection. BMC Pulm. Med., 16.","DOI":"10.1186\/s12890-016-0339-5"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.bjm.2017.06.001","article-title":"Antimicrobial resistance in Neisseria gonorrhoeae: History, molecular mechanisms and epidemiological aspects of an emerging global threat","volume":"48","author":"Moreira","year":"2017","journal-title":"Braz. J. Microbiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/00007435-198810000-00008","article-title":"Antibiotic resistance in Neisseria gonorrhoeae: Genetics and mechanisms of resistance","volume":"15","author":"Johnson","year":"1988","journal-title":"Sex. Transm. Dis."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1086\/422726","article-title":"Antimicrobial resistance in nontyphoid salmonella serotypes: A global challenge","volume":"39","author":"Su","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1051\/vetres:2001105","article-title":"Mechanisms of quinolone resistance in Salmonella","volume":"32","author":"Cloeckaert","year":"2001","journal-title":"Vet. Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"985","DOI":"10.3389\/fmicb.2019.00985","article-title":"Antibiotic Resistance in Salmonella Typhimurium Isolates Recovered from the Food Chain Through National Antimicrobial Resistance Monitoring System between 1996 and 2016","volume":"10","author":"Wang","year":"2019","journal-title":"Front. Microbiol."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Britto, C.D., Wong, V.K., Dougan, G., and Pollard, A.J. (2018). A systematic review of antimicrobial resistance in Salmonella enterica serovar Typhi, the etiological agent of typhoid. PLoS Negl. Trop. Dis., 12.","DOI":"10.1371\/journal.pntd.0006779"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Wang, D., Guo, Q., and Yuan, Y. (2019). The antibiotic resistance of Helicobacter pylori to five antibiotics and influencing factors in an area of China with a high risk of gastric cancer. BMC Microbiol., 19.","DOI":"10.1186\/s12866-019-1517-4"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1177\/1756283X11432492","article-title":"The challenge of Helicobacter pylori resistance to antibiotics: The comeback of bismuth-based quadruple therapy","volume":"5","year":"2012","journal-title":"Ther. Adv. Gastroenterol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.2174\/1381612003399077","article-title":"Antibiotic-resistant, H. pylori Infection and its treatment","volume":"6","author":"Qureshi","year":"2000","journal-title":"Curr. Pharm. Des."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1586\/14787210.2014.956092","article-title":"Mechanisms of antibiotic resistance in enterococci","volume":"12","author":"Miller","year":"2014","journal-title":"Expert Rev. Anti-Infect. Ther."},{"key":"ref_37","unstructured":"Levitus, M., Rewane, A., and Perera, T.B. (2020, June 10). Vancomycin-Resistant Enterococci (VRE), StatPearls [Internet], Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK513233\/."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3184\/003685002783238870","article-title":"Methicillin resistance in Staphylococcus aureus: Mechanisms and modulation","volume":"85","author":"Stapleton","year":"2002","journal-title":"Sci. Prog."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"01","DOI":"10.31080\/ASVS.2020.02.0046","article-title":"Antibacterial activity of Roussin\u2019s black salt $gainst multidrug resistant zoonotic pathogens isolated from companion animals","volume":"2","author":"Meade","year":"2020","journal-title":"Acta Sci. Vet. Sci."},{"key":"ref_40","first-page":"23","article-title":"Recent advances in the understanding of antibiotic resistance in Clostridium difficile infection","volume":"3","author":"Spigaglia","year":"2016","journal-title":"Ther. Adv. Infect. Dis."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0002-9343(98)00351-9","article-title":"Drug-resistant streptococcus pneumoniae: Rational antibiotic choices","volume":"106","author":"Jacobs","year":"1999","journal-title":"Am. J. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e361","DOI":"10.1097\/MJT.0000000000000551","article-title":"Antimicrobial resistant streptococcus pneumoniae","volume":"24","author":"Cherazard","year":"2017","journal-title":"Am. J. Ther."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3390\/antibiotics3030317","article-title":"Drug resistance mechanisms in Mycobacterium tuberculosis","volume":"3","author":"Palomino","year":"2014","journal-title":"Antibiotics"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1128\/AAC.41.3.540","article-title":"Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis","volume":"41","author":"Scorpio","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1128\/AAC.48.9.3412-3418.2004","article-title":"Genes required for intrinsic multidrug resistance in Mycobacterium avium","volume":"48","author":"Philalay","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1128\/CMR.05030-11","article-title":"Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria","volume":"25","author":"Nash","year":"2012","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Jaffr\u00e9, J., Aubry, A., Maitre, T., Morel, F., Brossier, F., and Robert, J. (2020). Rational choice of antibiotics and media for mycobacterium avium complex drug susceptibility testing. Front. Microbiol., 11.","DOI":"10.3389\/fmicb.2020.00081"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"6758","DOI":"10.1128\/AAC.01240-16","article-title":"Clinical characteristics, treatment outcomes, and resistance mutations associated with macrolide-resistant Mycobacterium avium complex lung disease","volume":"60","author":"Moon","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Argud\u00edn, M.A., Deplano, A., Meghraoui, A., Dod\u00e9mont, M., Heinrichs, A., Denis, O., Nonhoff, C., and Roisin, S. (2017). Bacteria from animals as a pool of antimicrobial resistance genes. Antibiotics, 6.","DOI":"10.3390\/antibiotics6020012"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Rozman, V., Bogovi\u010d Matija\u0161i\u0107, B., and Smole Mo\u017eina, S. (2019). Antimicrobial resistance of common zoonotic bacteria in the food chain: An emerging threat. Antimicrob. Resist. Glob. Threat.","DOI":"10.5772\/intechopen.80782"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/nyas.14058","article-title":"Critically important antibiotics: Criteria and approaches for measuring and reducing their use in food animal agriculture","volume":"1441","author":"Scott","year":"2019","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Santajit, S., and Indrawattana, N. (2016). Mechanisms of antimicrobial resistance in ESKAPE pathogens. BioMed Res. Int., 2475067.","DOI":"10.1155\/2016\/2475067"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3389\/fmicb.2019.00539","article-title":"Emerging strategies to combat ESKAPE pathogens in the era of antimicrobial resistance: A review","volume":"10","author":"Mulani","year":"2019","journal-title":"Front. Microbiol."},{"key":"ref_54","unstructured":"Savin, M., Bierbaum, G., Hammerl, J.A., Heinemann, C., Parcina, M., Sib, E., and Kreyenschmidt, J. (2020). Isolation and characterization of ESKAPE-bacteria and ESBL-producing E. coli from waste- and process water of German poultry slaughterhouses. Appl. Environ. Microbiol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jcmgh.2018.06.005","article-title":"Hidden dangers of antibiotic use: Increased gut permeability mediated by increased pancreatic proteases reaching the colon","volume":"6","author":"Spiller","year":"2018","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/628157","article-title":"Intestinal permeability in inflammatory bowel disease: Pathogenesis, clinical evaluation, and therapy of leaky gut","volume":"2015","author":"Michielan","year":"2015","journal-title":"Mediat. Inflamm."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s10067-017-3821-4","article-title":"The role of gut microbiota in the pathogenesis of rheumatic diseases","volume":"37","author":"Zhong","year":"2017","journal-title":"Clin. Rheumatol."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Batinovic, S., Wassef, F., Knowler, S.A., Rice, D.T.F., Stanton, C.R., Rose, J., Tucci, J., Nittami, T., Vinh, A., and Drummond, G.R. (2019). Bacteriophages in natural and artificial environments. Pathogens, 8.","DOI":"10.3390\/pathogens8030100"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41564-017-0053-y","article-title":"Discovery of an expansive bacteriophage family that includes the most abundant viruses from the human gut","volume":"3","author":"Yutin","year":"2017","journal-title":"Nat. Microbiol."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Sen\u00c4cilo, A., and Roine, E. (2014). A glimpse of the genomic diversity of haloarchaeal tailed viruses. Front. Microbiol., 5.","DOI":"10.3389\/fmicb.2014.00084"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0065-3527(08)60785-X","article-title":"Tailed bacteriophages: The order caudovirales","volume":"51","author":"Ackermann","year":"1998","journal-title":"Adv. Virus Res."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/382539","article-title":"Bacteriophages and their derivatives as biotherapeutic agents in disease prevention and treatment","volume":"2014","author":"Elbreki","year":"2014","journal-title":"J. Viruses"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1177\/153567601001500106","article-title":"Contained use of bacteriophages: Risk assessment and biosafety recommendations","volume":"15","author":"Verheust","year":"2010","journal-title":"Appl. Biosaf."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s12223-019-00729-9","article-title":"Evaluation of phage therapy in the treatment of Staphylococcus aureus-induced mastitis in mice","volume":"65","author":"Geng","year":"2020","journal-title":"Folia Microbiol. (Praha)"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.micres.2018.04.007","article-title":"Biotechnological applications of bacteriophages: State of the art","volume":"212\u2013213","author":"Harada","year":"2018","journal-title":"Microbiol. Res."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s12223-011-0039-8","article-title":"The influence of external factors on bacteriophages\u2014Review","volume":"56","year":"2011","journal-title":"Folia Microbiol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0923-2508(03)00067-6","article-title":"Bacteriophage observations and evolution","volume":"154","author":"Ackermann","year":"2003","journal-title":"Res. Microbiol."},{"key":"ref_68","first-page":"542","article-title":"Phage lytic proteins: Biotechnological applications beyond clinical antimicrobials","volume":"36","author":"Donovan","year":"2016","journal-title":"Crit. Rev. Biotechnol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"354","DOI":"10.4161\/viru.24498","article-title":"Importance of prophages to evolution and virulence of bacterial pathogens","volume":"4","author":"Fortier","year":"2013","journal-title":"Virulence"},{"key":"ref_70","unstructured":"Freeman, W.H. (2020, June 10). Modern Genetic Analysis, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK21342\/."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1128\/JB.186.12.3677-3686.2004","article-title":"Phage-host interaction: An ecological perspective","volume":"186","author":"Bruttin","year":"2004","journal-title":"J. Bacteriol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1128\/AEM.02382-15","article-title":"Isolation of polyvalent bacteriophages by sequential multiple-host approaches","volume":"82","author":"Yu","year":"2016","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"31","DOI":"10.4161\/bact.1.1.14942","article-title":"Phages in nature","volume":"1","author":"Clokie","year":"2011","journal-title":"Bacteriophage"},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Xu, Y., Yu, X., Gu, Y., Huang, X., Liu, G., and Liu, X. (2018). Characterization and genomic study of phage vB_EcoS-B2 infecting multidrug-resistant Escherichia coli. Front. Microbiol.","DOI":"10.3389\/fmicb.2018.00793"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1089\/vim.2013.0128","article-title":"Phage neutralization by sera of patients receiving phage therapy","volume":"27","author":"Zaczek","year":"2014","journal-title":"Viral Immunol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1093\/cid\/cit771","article-title":"Antibacterial bioagents based on principles of bacteriophage biology: An overview","volume":"58","author":"Knoll","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"273","DOI":"10.4172\/1747-0862.1000049","article-title":"Control of Campylobacter spp. and Yersinia enterocolitica by virulent bacteriophages","volume":"6","author":"Orquera","year":"2012","journal-title":"J. Mol. Genet. Med."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmicb.2016.01631","article-title":"Modular Approach to Select Bacteriophages Targeting Pseudomonas aeruginosa for Their Application to Children Suffering with Cystic Fibrosis","volume":"7","author":"Krylov","year":"2016","journal-title":"Front. Microbiol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1093\/jpids\/pix056","article-title":"Refractory pseudomonas bacteremia in a 2-year-old sterilized by bacteriophage therapy","volume":"7","author":"Duplessis","year":"2018","journal-title":"J. Pediatric Infect. Dis. Soc."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13054-017-1709-y","article-title":"Use of bacteriophages in the treatment of colistin-only-sensitive Pseudomonas aeruginosa septicaemia in a patient with acute kidney injury-a case report","volume":"21","author":"Jennes","year":"2017","journal-title":"Crit. Care"},{"key":"ref_81","first-page":"168","article-title":"The disparate effects of bacteriophages on antibiotic-resistant bacteria","volume":"7","year":"2018","journal-title":"Emerg. Microbes Infect."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.crvi.2005.09.010","article-title":"In situ measurements of viral particles diffusion inside mucoid biofilms","volume":"328","author":"Briandet","year":"2005","journal-title":"Comptes Rendus Biol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"e01379-14","DOI":"10.1128\/mBio.01379-14","article-title":"Engineered endolysin-based \u201cArtilysins\u201d to combat multidrug-resistant gram-negative pathogens","volume":"5","author":"Briers","year":"2014","journal-title":"MBio"},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Sausset, R., Petit, M.A., Gaboriau-Routhiau, V., and De Paepe, M. (2020). New insights into intestinal phages. Mucosal Immunol.","DOI":"10.1038\/s41385-020-0260-3"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1002\/med.21572","article-title":"Phage therapy: What factors shape phage pharmacokinetics and bioavailability? Systematic and critical review","volume":"39","author":"Dabrowska","year":"2019","journal-title":"Med. Res. Rev."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1080\/03009734.2019.1688433","article-title":"Pharmacological limitations of phage therapy","volume":"124","author":"Nilsson","year":"2019","journal-title":"Upsala J. Med. Sci."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"e24219","DOI":"10.4161\/bact.24219","article-title":"Phage therapy","volume":"3","author":"Jalasvuori","year":"2013","journal-title":"Bacteriophage"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4161\/bact.1.2.14590","article-title":"Pros and cons of phage therapy","volume":"1","author":"Abedon","year":"2011","journal-title":"Bacteriophage"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1093\/cid\/cix184","article-title":"The lysis of pathogenic Escherichia coli by bacteriophages releases less endotoxin than by \u03b2-lactams","volume":"64","author":"Dufour","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"981","DOI":"10.3389\/fmicb.2017.00981","article-title":"Editorial: Phage therapy: Past, present and future","volume":"8","author":"Abedon","year":"2017","journal-title":"Front. Microbiol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1128\/AAC.04641-14","article-title":"Novel phage lysin capable of killing the multidrug-resistant Gram-negative bacterium Acinetobacter baumannii in a mouse bacteremia model","volume":"59","author":"Lood","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Cooper, C.J., Koonjan, S., and Nilsson, A.S. (2018). Enhancing whole phage therapy and their derived antimicrobial enzymes through complex formulation. Pharmaceuticals, 11.","DOI":"10.3390\/ph11020034"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1146\/annurev-food-032818-121747","article-title":"Bacteriophages in food applications: From foe to friend","volume":"10","author":"Bolton","year":"2019","journal-title":"Annu. Rev. Food Sci. Technol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s12985-019-1260-3","article-title":"Veterinary use of bacteriophage therapy in intensively-reared livestock","volume":"16","author":"Gigante","year":"2019","journal-title":"Virol. J."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3923\/pjbs.2014.301.315","article-title":"Bacteriophage therapy for safeguarding animal and human health: A review","volume":"17","author":"Tiwari","year":"2014","journal-title":"Pak. J. Boil. Sci."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3389\/fcimb.2018.00376","article-title":"Bacteriophage therapy: Clinical trials and regulatory hurdles","volume":"8","author":"Furfaro","year":"2018","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.3168\/jds.2015-9748","article-title":"In vitro evaluation of a novel bacteriophage cocktail as a preventative for bovine coliform mastitis","volume":"99","author":"Porter","year":"2016","journal-title":"J. Dairy Sci."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1086\/521305","article-title":"Efficient Elimination of Multidrug-Resistant Staphylococcus aureus by Cloned Lysin Derived from Bacteriophage \u03c6MR11","volume":"196","author":"Rashel","year":"2007","journal-title":"J. Infect. Dis."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1128\/IAI.70.1.204-210.2002","article-title":"Bacteriophage therapy rescues mice bacteremic from a clinical isolate of vancomycin-resistant Enterococcus faecium","volume":"70","author":"Biswas","year":"2002","journal-title":"Infect. Immun."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"149","DOI":"10.4161\/bact.21868","article-title":"Bacteriophages and dairy fermentations","volume":"2","author":"Moineau","year":"2012","journal-title":"Bacteriophage"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"172","DOI":"10.4314\/ovj.v8i2.10","article-title":"Mycobacterium avium subspecies paratuberculosis: A causative agent in human morbidity and risk to public health safety","volume":"8","author":"Garvey","year":"2018","journal-title":"Open Vet. J."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1007\/s00705-014-2122-3","article-title":"Isolation and characterization of a novel bacteriophage against mycobacterium avium subspecies paratuberculosis","volume":"159","author":"Basra","year":"2014","journal-title":"Arch. Virol."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Chaturongakul, S., and Ounjai, P. (2014). Phage\u00e2\u20ac\u201chost interplay: Examples from tailed phages and Gram-negative bacterial pathogens. Front. Microbiol., 5.","DOI":"10.3389\/fmicb.2014.00442"},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Ramisetty, B.C.M., and Suhakari, P.A. (2019). Bacterial \u2018Grounded\u2019 Prophages: Hotspots for genetic renovation and innovation. Front. Genet., Available online: https:\/\/doi.org\/10.3389\/fgene.2019.00065.","DOI":"10.3389\/fgene.2019.00065"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1128\/MMBR.68.3.560-602.2004","article-title":"Phages and the evolution of bacterial pathogens: From genomic rearrangements to lysogenic conversion","volume":"68","author":"Brussow","year":"2004","journal-title":"Microbiol. Mol. Boil. Rev."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"513","DOI":"10.3389\/fphar.2019.00513","article-title":"Advantages and limitations of bacteriophages for the treatment of bacterial infections","volume":"10","author":"Principi","year":"2019","journal-title":"Front. Pharmacol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1046\/j.1365-2958.2001.02554.x","article-title":"KP4 fungal toxin inhibits growth in Ustilago maydis by blocking calcium uptake","volume":"41","author":"Gage","year":"2001","journal-title":"Mol. Microbiol."},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Gorski, A., Bollyky, P.L., Przybylski, M., Borysowski, J., Jonczyk-Matysiak, E., and Weber-Dabrowska, B. (2019). Perspectives of phage therapy in non-bacterial infections. Front. Microbiol., 9.","DOI":"10.3389\/fmicb.2018.03306"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s10096-010-0946-7","article-title":"Mycoviruses: Future therapeutic agents of invasive fungal infections in humans?","volume":"29","author":"Sande","year":"2010","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_110","first-page":"69","article-title":"Zygocin, a secreted antifungal toxin of the yeast Zygosaccharomyces bailii, and its effect on sensitive fungal cells","volume":"3","author":"Weiler","year":"2003","journal-title":"FEMS Yeast Res."}],"container-title":["Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-6382\/9\/7\/414\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:49:00Z","timestamp":1760176140000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-6382\/9\/7\/414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,16]]},"references-count":110,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,7]]}},"alternative-id":["antibiotics9070414"],"URL":"https:\/\/doi.org\/10.3390\/antibiotics9070414","relation":{},"ISSN":["2079-6382"],"issn-type":[{"value":"2079-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,16]]}}}